Universe Pharmaceuticals (UPC) Prepaid Assets (2021 - 2025)
Universe Pharmaceuticals (UPC) reported Prepaid Assets of $177.9 million for Q3 2025, up 472.21% on a YoY basis from $31.1 million in Q3 2024, and up 472.21% sequentially from $31.1 million in Q3 2024.
Universe Pharmaceuticals (UPC) Prepaid Assets (2021 - 2025) Analysis & Trends
Universe Pharmaceuticals (UPC) has 5 years of Prepaid Assets data on file, last reported at $177.9 million in Q3 2025.
- For the quarter ending Q3 2025, Prepaid Assets rose 472.21% year-over-year to $177.9 million; the trailing twelve-month figure through Sep 2025 stood at $177.9 million (up 472.21% YoY), and the FY2025 full-year result was $177.9 million, up 472.21% from the prior year.
- Prepaid Assets advanced to $177.9 million in Q3 2025, from $31.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $177.9 million in Q3 2025 to a low of $74300.0 in Q3 2023.
- A 5-year average of $26.7 million and a median of $1.1 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 95.69% in 2023 and surged 41743.88% in 2024, its largest moves.
- Tracing UPC's Prepaid Assets over 5 years: stood at $174053.0 in 2021, then jumped by 890.56% to $1.7 million in 2022, then sank by 95.69% to $74300.0 in 2023, then soared by 41743.88% to $31.1 million in 2024, then jumped by 472.21% to $177.9 million in 2025.
- Business Quant data shows UPC's Prepaid Assets at $177.9 million in Q3 2025, $31.1 million in Q3 2024, and $539240.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 177.90 Mn |
| Sep 30, 2024 | 31.09 Mn |
| Mar 31, 2024 | 539,240.00 |
| Sep 30, 2023 | 74,300.00 |
| Mar 31, 2023 | 2.01 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 418,170.00 |
| Sep 30, 2021 | 174,053.00 |